Treatment of Neuroendocrine Tumors Treatment in India

What are Neuroendocrine Tumors (NETs)?

Neuroendocrine tumors (NETs) are rare tumors that arise from specialized cells called neuroendocrine cells. These tumors can occur in various organs throughout the body, such as the lungs, pancreas, gastrointestinal tract, and other areas. Neuroendocrine tumors can be benign or malignant and may produce hormones, leading to distinct clinical symptoms.

What is the Cost of Neuroendocrine Tumors Treatment?

The cost of neuroendocrine tumors treatment can vary depending on factors such as the type and stage of the tumor, treatment modalities involved (surgery, chemotherapy, radiation therapy, etc.), the location of the hospital, and individual factors. It is recommended to consult with healthcare providers and insurance companies to obtain accurate cost estimates and information about coverage.

Technology used in Neuroendocrine Tumors Treatment:

• Surgical Techniques: Advanced surgical approaches, including minimally invasive and robotic-assisted surgeries, may be employed for the removal of neuroendocrine tumors.
• Radiation Therapy: Techniques such as intensity-modulated radiation therapy (IMRT) or stereotactic radiosurgery (SRS) may be utilized to deliver precise radiation doses to the tumor while minimizing damage to surrounding healthy tissues.
• Targeted Therapy: Medications targeting specific molecular markers and signaling pathways in neuroendocrine tumors, such as somatostatin analogs or tyrosine kinase inhibitors, may be used to inhibit tumor growth and control symptoms.
• Peptide Receptor Radionuclide Therapy (PRRT): This therapy involves the administration of radioactive substances that specifically target neuroendocrine tumor cells, delivering radiation directly to the tumor and minimizing damage to healthy tissues.

Key Tests after Neuroendocrine Tumors Treatment:

• Regular imaging studies such as CT scans, MRI, or PET scans may be performed to monitor the tumor, evaluate treatment response, and detect any recurrence or metastasis.
• Blood tests to assess biomarkers and hormone levels associated with neuroendocrine tumors may be conducted to monitor disease progression or response to treatment.